Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Bafna Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE
Add to

57/100
111.32
-0.64 (-0.57%)

As on 02 Apr, 2026 | 03:53

Open Trading A/c
Day Range
109.55
115.00
L H
52 Week Range
70.61
202.06
L H
Volume
1,830
*
i

* BSE Market Depth (02 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
35 111.20 0.00 0
10 110.50 0.00 0
22 108.55 0.00 0
1000 108.00 0.00 0
0 0.00 0.00 0
0 Total Total 0
Bid / Ask
0.00 / 0.00
Compare Stocks Advanced Chart
57/100
111.00
-2.35 (-2.07%)

As on 02 Apr, 2026 | 04:01

Open Trading A/c
Day Range
108.25
111.10
L H
52 Week Range
71.65
204.95
L H
Volume
559
*
i

* BSE Market Depth (02 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
35 111.20 0.00 0
10 110.50 0.00 0
22 108.55 0.00 0
1000 108.00 0.00 0
0 0.00 0.00 0
0 Total Total 0
Bid / Ask
0.00 / 0.00
Compare Stocks Advanced Chart
NSE
MC Essentials
59% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, Low Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 111.96
          Previous Close 111.96
          Volume 1,830.00
          Value (Lacs) 2.04
            VWAP 112.77
          Beta
          Mkt Cap (Rs. Cr.) 263
          High 115.00
          Low 109.55
          UC Limit 117.55
          LC Limit 106.37
          52 Week High 202.06
          52 Week Low 70.61
          Face Value 10.00
          All Time High 233.55
          All Time Low 3.55
          20D Avg Volume 6,032
          20D Avg Delivery(%) 77.75
          Book Value Per Share 7.21
          Dividend Yield 0.00
          TTM EPS See historical trend -10.45 (+124.67% YoY)
          TTM PE See historical trend -- (Average PE)
          P/B See historical trend 15.44 (Average P/B)
          Sector PE 38.51

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          57/100
          Superior Financial Strength, Low Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 44.91% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 75.00% in Dec 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          8 out of 13 years Bafna Pharmaceuticals has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 46.33% (2014) 11.24% -8.81% (2019) -4.60% 5.15%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling

          What's your call on  today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          About the Company

          Bafna PharmaceuticalsLtd is engaged in the production of tablets , capsule and oral syrup. The company is currently focusing on prescription drugs in the global market and contract manufacturing and dossier filing in regulated markets.Their product range includes Antibacterials,Antipyretics,Anticonvulsants,Anxiolytics,Pain management,Anthelmintics,Antifungal,Appetite stimulants,Antidiarrhoeals,Antiemetics,Hypnotics,Antacids and antiulcerants,Vitamin and dietery preparation,Cough and cold preparations,Antiasthmatics,Calcium preparations,Antihypertensives& Antidiabetics
          {"success":1,"data":{"address":{"address1":"Bafna Towers,\n","address2":"New\u00a0No.\u00a068,\u00a0Old\u00a0No. 299,,\nThambu Chetty Street,","city":"Chennai (Madras)","state":"Tamil Nadu","pincode":"600001","telephone1":"044-42677555","telephone2":"","fax1":"044-42677599","fax2":"","email":"info@bafnapharma.com","web":"http:\/\/www.bafnapharma.com"},"management":[{"name":"S Hemalatha","designation":"Whole Time Director"},{"name":"Vinayak Dinesh Dendukuri","designation":"Whole Time Director"},{"name":"Upendar Mekala Reddy","designation":"Non Exe.Non Ind.Director"},{"name":"Akila C Raju","designation":"Non Exe.Non Ind.Director"},{"name":"R Chitra","designation":"Ind. Non-Executive Director"}],"registrars":{"name":"Cameo Corporate Services Ltd.","address1":"\"Subramanian Building\",\nNo.1, Vth Floor,\nClub Hous","address2":"","address3":"","address4":"","telephone":"044-28460390 (5 Lines)","fax":"044-28460129","email":"investor@cameoindia.com","internet":"http:\/\/www.cameoindia.com","city":"Chennai (Madras)","state":"Tamil Nadu","pincode":"600002"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"532989","nseId":"BAFNAPH","series":"EQ","isinid":"INE878I01022"}}}

          • Registered Office

            • Address

              Bafna Towers, ,New No. 68, Old No. 299,, Thambu Chetty Street,

            • City

              Chennai (Madras)

            • State

              Tamil Nadu

            • Pin Code

              600001

            • Tel. No.

              044-42677555

            • Fax No.

              044-42677599

            • Email

              info@bafnapharma.com

            • Internet

              http://www.bafnapharma.com

          • Registrars

          • Management

            • S Hemalatha

              Whole Time Director

            • Vinayak Dinesh Dendukuri

              Whole Time Director

            • Upendar Mekala Reddy

              Non Exe.Non Ind.Director

            • Akila C Raju

              Non Exe.Non Ind.Director

            • R Chitra

              Ind. Non-Executive Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              532989

            • NSE:

              BAFNAPH

            • Series

              EQ

            • ISIN

              INE878I01022

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347